Skip to main content
AB

Araceli Biosciences

Araceli Biosciences provides the Endeavor® portfolio of high‑content imaging systems that deliver sub‑micron resolution and ultra‑high‑throughput acquisition for 96‑, 384‑, and 1536‑well plates. Integrated hardware and software stream full‑plate images in minutes and feed real‑time, analysis‑ready data into cloud‑based AI/ML pipelines, enabling pharmaceutical, biotech, and academic researchers to accelerate phenotypic screening, candidate selection, and drug discovery.

Portland, United StatesFounded 2020463K+ followers
Updated 2 months ago

Funding

$11.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

BC
Funding rounds are not available yet.

Founders

Product

Problem

Drug discovery workflows often rely on low-throughput, manual imaging and analysis, causing delays in data generation and increasing the risk of costly downstream failures. Researchers need faster, high‑resolution imaging that can handle 96‑ to 1536‑well plates while delivering real‑time, analysis‑ready data.

Solution

Araceli Biosciences offers the Endeavor® portfolio of high‑content imaging systems that combine sub‑micron resolution with ultra‑high‑throughput acquisition across 96, 384, and 1536‑well formats. The platforms capture full‑plate images in minutes (e.g., 1536‑well plates in under four minutes) and feed data directly into cloud‑based AI/ML pipelines for immediate, actionable insights. Integrated software—including EndeavorOS acquisition, ClaireRT real‑time monitoring, and Clairvoyance analysis—provides automated quality control, machine‑learning‑driven phenotype extraction, and intuitive visualization, enabling scientists to make rapid decisions and accelerate candidate selection.

Target Audience

Primary customers are pharmaceutical and biotech R&D teams, as well as academic research labs, that require high‑throughput phenotypic screening, cell painting, and live‑cell assays for drug discovery and target validation.

Features

  • Sub‑micron (0.27 µm/pixel) resolution with 20×, 0.75 NA objective and 1.1″ CMOS sensor (4400 × 4400 px)
  • Supports 96, 384, and 1536‑well plates with laser autofocus and multi‑channel LED illumination (390‑630 nm)
  • Ultra‑high throughput: up to 283 plates/day (≈1,984 plates/week) for the Ultra model; Pro and Core models deliver 66–212 plates/day
  • Real‑time data streaming and on‑instrument analysis via ClaireRT; downstream AI/ML analysis with Clairvoyance software
  • Automated quality‑control, flat‑field correction, and user‑friendly UI for protocol building and batch processing
  • Scalable software stack (EndeavorOS) shared across all hardware models for consistent operation and data handling
  • Compatibility with common fluorescent dyes and stains (DAPI, GFP, mCherry, etc.) and ability to export data for downstream AI pipelines
This profile is AI-generated and may contain inaccuracies.